PL434721A1 - New disulphonamide derivatives of 5-aniline-1-phenyl-3-methyl-1H-pyrazol[ 4,3-e][1,2,4]-triazine with anti-tumor properties, method for synthetizing them, pharmaceutical compositions that contain these derivatives and their first medical application - Google Patents

New disulphonamide derivatives of 5-aniline-1-phenyl-3-methyl-1H-pyrazol[ 4,3-e][1,2,4]-triazine with anti-tumor properties, method for synthetizing them, pharmaceutical compositions that contain these derivatives and their first medical application

Info

Publication number
PL434721A1
PL434721A1 PL434721A PL43472120A PL434721A1 PL 434721 A1 PL434721 A1 PL 434721A1 PL 434721 A PL434721 A PL 434721A PL 43472120 A PL43472120 A PL 43472120A PL 434721 A1 PL434721 A1 PL 434721A1
Authority
PL
Poland
Prior art keywords
amino
derivatives
methyl
phenyl
new
Prior art date
Application number
PL434721A
Other languages
Polish (pl)
Other versions
PL240932B1 (en
Inventor
Mariusz Mojzych
Zofia Bernat
Anna Bielawska
Krzysztof Bielawski
Anna SZYMANOWSKA
Katarzyna Kotwica-Mojzych
Original Assignee
Uniwersytet Przyrodniczo-Humanistyczny W Siedlcach
Uniwersytet Medyczny W Białymstoku
Uniwersytet Medyczny W Lublinie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczo-Humanistyczny W Siedlcach, Uniwersytet Medyczny W Białymstoku, Uniwersytet Medyczny W Lublinie filed Critical Uniwersytet Przyrodniczo-Humanistyczny W Siedlcach
Priority to PL434721A priority Critical patent/PL240932B1/en
Publication of PL434721A1 publication Critical patent/PL434721A1/en
Publication of PL240932B1 publication Critical patent/PL240932B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku są nowe disulfonamidowe pochodne 5-anilino-7-fenylo-pirazolo[4,3-e][1,2,4]triazyny przedstawione ogólnym wzorem 1, które charakteryzują się tym, że R oznacza podstawnik będący grupą: N-metylopiperazynową, pirolidynową, morfolinową, piperydynową, piperazynową, homopiperazynową, 2-morfolinoetyloaminową, 2-aminoetyloaminową, 2-aminoetanolowa, 2-amino-2-metylo-1,3-propanodiolową, 2-amino-2-metylo-1-propanolową, (S)-(+)-1-amino-2-propanolową, (R)-(-)-1-amino-2-propanolową, (S)-(+)-2-amino-1-propanolową, (R)-(-)-2-amino-1-propanolową, (S)-(+)-2-amino-3-metylo-1-butanolową, (R)-(-)-2-amino-3-metylo-1-butanolową, (S)-(+)-3-amino-1,2-propanodiolową, (R)-(-)-2-amino-1,2-propanodiolową, (S)-(+)-leucinolową, (R)-(-)-leucinolową, S-(+)-2-amino-1-butanolową, R-(-)-2-amino-1-butanolową, ester metylowy L-proliny i ester metylowy cis-4-hydroksy-L-proliny. Związki według wynalazku wykazują aktywność przeciwnowotworową, cytostatyczną, cytotoksyczną i antyproliferacyjną. Przedmiotem wynalazku jest także nowy sposób wytwarzania disulfonamidowych pochodnych 5-anilino-7-fenylo-pirazolo[4,3-e][1,2,4] o ogólnym wzorze 1, a także zastosowania takich związków i kompozycja farmaceutyczna je zawierająca.The subject of the invention are new disulfonamide derivatives of 5-anilino-7-phenyl-pyrazolo [4,3-e] [1,2,4] triazines represented by the general formula 1, which are characterized in that R represents a substituent which is the group: N-methylpiperazine ( S) - (+) - 1-amino-2-propanol, (R) - (-) - 1-amino-2-propanol, (S) - (+) - 2-amino-1-propanol, (R) - (-) - 2-amino-1-propanol, (S) - (+) - 2-amino-3-methyl-1-butanol, (R) - (-) - 2-amino-3-methyl-1 -butanol, (S) - (+) - 3-amino-1,2-propanediol, (R) - (-) - 2-amino-1,2-propanediol, (S) - (+) - leucinol, ( R) - (-) - leucinol, S - (+) - 2-amino-1-butanol, R - (-) - 2-amino-1-butanol, L-proline methyl ester and cis-4-hydroxy methyl ester -L-proline. The compounds of the invention exhibit antitumor, cytostatic, cytotoxic and antiproliferative activities. The invention also relates to a new process for the preparation of 5-anilino-7-phenyl-pyrazolo [4,3-e] [1,2,4] disulfonamide derivatives of the general formula 1, as well as to the use of such compounds and a pharmaceutical composition thereof.

PL434721A 2020-07-17 2020-07-17 New disulphonamide derivatives of 5-aniline-1-phenyl-3-methyl-1H-pyrazol[ 4,3-e][1,2,4]-triazine with anti-tumor properties, method for synthetizing them, pharmaceutical compositions that contain these derivatives and their first medical application PL240932B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL434721A PL240932B1 (en) 2020-07-17 2020-07-17 New disulphonamide derivatives of 5-aniline-1-phenyl-3-methyl-1H-pyrazol[ 4,3-e][1,2,4]-triazine with anti-tumor properties, method for synthetizing them, pharmaceutical compositions that contain these derivatives and their first medical application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434721A PL240932B1 (en) 2020-07-17 2020-07-17 New disulphonamide derivatives of 5-aniline-1-phenyl-3-methyl-1H-pyrazol[ 4,3-e][1,2,4]-triazine with anti-tumor properties, method for synthetizing them, pharmaceutical compositions that contain these derivatives and their first medical application

Publications (2)

Publication Number Publication Date
PL434721A1 true PL434721A1 (en) 2022-01-24
PL240932B1 PL240932B1 (en) 2022-07-04

Family

ID=80111535

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434721A PL240932B1 (en) 2020-07-17 2020-07-17 New disulphonamide derivatives of 5-aniline-1-phenyl-3-methyl-1H-pyrazol[ 4,3-e][1,2,4]-triazine with anti-tumor properties, method for synthetizing them, pharmaceutical compositions that contain these derivatives and their first medical application

Country Status (1)

Country Link
PL (1) PL240932B1 (en)

Also Published As

Publication number Publication date
PL240932B1 (en) 2022-07-04

Similar Documents

Publication Publication Date Title
PH12022552745A1 (en) [1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS
GEAP202215475A (en) 2-amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors
CN117157299A8 (en) Tricyclic heterocyclic derivative, composition and application thereof
KR20060009371A (en) Pharmaceutical composition containing histone deacetylase inhibitor
HRP20050710A2 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
ATE481401T1 (en) TETRAHYDRO-4H-PYRIDOÄ1,2-AÜPYRIMIDINES AND RELATED COMPOUNDS USABLE AS HIV INTEGRASE INHIBITORS
ATE455786T1 (en) 6-11 BICYCLIC KETOLIDE DERIVATIVES
HRP20200566T1 (en) Novel combination treatment for acute myeloid leukemia (aml)
MX2024003988A (en) PYRROLLO-BENZODIAZEPINE DERIVATIVE AND CONJUGATE, METHOD OF PREPARATION AND USE THEREOF.
PH12022553420A1 (en) Amidopyrimidone derivatives
MX2022016263A (en) Cyclobutyl-urea derivatives.
MX2025009943A (en) Camptothecin derivative, conjugate thereof, preparation method therefor and medical use thereof
BR112019018615A2 (en) antimicrobial compounds, compositions and uses thereof
PH12022552454A1 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharmaceutically acceptable salt, hydrate, or solvate thereof
RU2019142111A (en) ANTI-TUMOR EFFECT AMPLIFIER WITH THE APPLICATION OF A NEW BIPHENYL COMPOUND
GEAP202115310A (en) CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND THEIR USE
PL434721A1 (en) New disulphonamide derivatives of 5-aniline-1-phenyl-3-methyl-1H-pyrazol[ 4,3-e][1,2,4]-triazine with anti-tumor properties, method for synthetizing them, pharmaceutical compositions that contain these derivatives and their first medical application
MX2023009954A (en) Aminopyrimidine compounds and methods of their use.
JOP20240171A1 (en) Uracil compounds with N3 substitution in the form of TRPA1 inhibitors
MX2021000403A (en) COMPOSITION OF FUSIONED GAMMA TRICYCLIC AMINO ACID DERIVATIVES AND THE PREPARATION THEREOF.
WO2005070113A3 (en) 9n-substituted 6-11 bicyclic erythromycin derivatives
WO2024015916A3 (en) 4'-alkyne-2'-deoxycytidine-based compounds and anti-cancer uses thereof
WO2005067564A3 (en) 6-11 bicyclic erythromycin derivatives
JP2023516494A5 (en)
EA200970537A1 (en) ANTIBACTERIAL DERIVATIVES OF QUINOLINE